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Solution for Asymptomatic Carotid Stenosis. Letter to
the Editors of Journal of Vascular Surgery and the
European Journal of Vascular and Endovascular
Surgery regarding Trans-Atlantic Debate No. 1.Dear Editor,
Current medical intervention alone is now best for preven-
tion of stroke associated with asymptomatic carotid
stenosis.1 Dr Schneider’s case against this conclusion is
fatally flawed because it is based on an outdated, over-
reliance on borderline significant results from historical
randomised carotid endarterectomy (CEA) trials (‘level 1
evidence’) and underestimation of the counter-evidence.1,2
There have been significant falls in average annual rates
of ipsilateral and any territory stroke (þ/ TIA) with
medical intervention alone since the early 1980s, rates
falling below those of patients who received medical
intervention and CEA in randomised trials.1 These falls were
revealed after a thorough, systematic literature analysis
limited to prospective studies of >100 patients with direct-
imaging-identified asymptomatic carotid stenosis of
50e75% using NASCET/NASCET comparable measure-
ments. There were 3724 patients, including those from
randomised trials, with average followup of about 3e4
years. Whether randomised to surgery or not, patients had
similar stenosis severity (>50%/60% in the randomised
trials, for example). Subsequent publications have been
consistent with a continuing drop in stroke event rates with
current medical intervention alone. The conclusion current
medical intervention alone is now best for prevention of
stroke associated with asymptomatic severe carotid
stenosis is based on all currently available evidence; these
published annual stroke rates, consideration of non-stroke/
death atherosclerotic complications, observations of
routine practice CEA and cost.3
We need more measurements of the average annual risk
of stroke, and other major atherosclerotic complications,
among well described patients with asymptomatic carotid
stenosis receiving well described current medical interven-
tion alone. Current common-place and current bestmedical
intervention are ever evolving concepts that will vary acrossDOI of original articles: 10.1016/j.ejvs.2010.05.004, 10.1016/
j.jvs.2010.05.063.time and locality. Therefore, we need to make such
measurements an ongoing, integral part of routine practice
around the world. We also need to keep defining current
medical intervention by updating optimal ways to identify
and treat risk factors to best prevent clinical complications.
The average annual ipsilateral stroke rate among
hospital-referred patients with asymptomatic severe
carotid stenosis receiving current medical intervention
alone is now expected to be consistently <1%, perhaps
<0.5%. Therefore, what clinical or economic benefit could
be expected for routine practice from further randomised
trials of additional surgery/stenting in this setting? None!
Instead we need to identify the small minority with suffi-
ciently higher than average risk despite current best
medical intervention alone. We can expect such patients
will also be at higher risk from CEA/stenting. Therefore, we
would need to randomise them to additional CEA/stenting
(and only them!). The results of such randomised trials will
not be available for >10e15 years. So, in the mean time,
we should stop operating, stop stenting, better deliver
current best medical intervention and better measure!Conflict of interest
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Response to comment Regarding Trans-Atlantic
Debate: Asymptomatic Carotid Artery StenosisDear Editor,
The letter from Dr. Abbott adds nothing new, except perhaps
a bit of bluster. I need to know how asymptomatic carotid
stenosis should be managed and I am not going to find out
from Dr. Abbott’s letter. The paper referenced in the letter
by Dr. Abbott as holding the answer to this problemwas cited
by both Mr. Naylor and myself in the preceding debate.1 I
encourage everyone to read thepaper cited by both debaters
and by the letter and examine the studies from which it is
derived. Many of you will be horrified with what you find;
small, poorly controlled studies of patients with no neuro-
logical examination, lots of crossovers, unclear duplex find-
ings, and many minor carotid lesions. We are being told that
the answer has been “discovered” through a review of these
earlier studies.
The ACST was better conducted than any single study
cited as a reason to abandon repair of carotid stenosis. When
have marginal studies, even a lot of them, trumped level 1
evidence? When does a review paper hold the answer while
awell conducted RCT does not? The debatewas written prior
to the publication of the CREST but the letter by Dr. Abbott
was written since.2 Now we all know that asymptomatic
patients had a perioperative stroke/death risk of 1.4% with
endarterectomy. Suppose the annual risk of stroke without
repair is as low as 1% as has been suggested (we still don’t
know)? Any patient with a life expectancy ofmore than a few
years could still potentially benefit.
It may come to pass that medical management solves
this problem. However, evidence being cited that repair
should be abandoned is far from conclusive. Only the
convictions of the proponents of that nihilistic approach are
clear. How can anyone be so certain that it is time to
abandon repair?
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Comments regarding ‘A New Endovascular Approach to
Exclude Isolated Bilateral Common Iliac Artery
Aneurysms’. Eur J Vasc Endovasc Surg Extra 2010;19
(6) e55e7Dear Editor,
I read with interest the innovative technique described by
Frigatti et al.1 Therein, a bilateral iliac aneurysm is excluded
endoluminally and the ‘chimney’ technique is utilized to
preserve the flow into one internal iliac artery (IIA)whilst the
other was intentionally occluded. In cases such as these it is
useful to reconsider the sequelae of unilateral and bilateral
iliac occlusion. Contrary to popular perception, intentional
unilateral IIA occlusion appears to carry a similar risk of
symptoms as bilateral, ranging from 9 to 45%.2 Neither
statistically significant difference in incidence of pelvic
ischaemia nor sexual dysfunction has been shown between
unilateral andbilateral IIA occlusions.2 Accordingly efforts to
preserve bilateral IIA perfusion are justifiable, particularly in
younger and active patients.
The use of iliac branch devices (IBD) for such cases should
not be discounted, and their successful use to perfuse both
IIAs has been described.3 For these devices it is recom-
mended that the target common iliac artery should have
a length of at least 50 mm and a minimal diameter of 20 mm
adjacent to the side branch. In addition to these consider-
ations, a wide aortic bifurcation, aminimal IIA tortuosity and
a long IIA landing zoneare favorable anatomic factors.Within
these constraints, a recent review has found that contem-
porary IBD procedures may be performedwith high technical
success rates and are associated with encouraging mid-term
patency of IIA in selected patients. Only 24 out of a collated
total of 196patients occluded the IIA stent, ofwhomonly half
became symptomatic.4 In experienced centres, deployment
of an IBD does not add a significant additional operating time
and issues such as kinking or thrombotic occlusion can be
dealt with endovascular means. Though ‘chimney’ stents are
a valuable addition to the vascular specialist repertoire, the
medium- and long-term performance of these stents is not
yet reported.DOI of original article: 10.1016/j.ejvsextra.2010.02.002.
